Terms: = Kidney tumors AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha
396 results:
1. Expression of HIF‑α and their association with clinicopathological parameters in clinical renal cell carcinoma.
Sitaram RT; Ljungberg B
Ups J Med Sci; 2024; 129():. PubMed ID: 38571885
[TBL] [Abstract] [Full Text] [Related]
2. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
3. Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance.
Mohammadipoor N; Naiebi R; Mazhari SA; Amooei F; Owrang M; Dastghaib S; Shams M; Maleki MH; Dastghaib S
Mol Biol Rep; 2024 Mar; 51(1):379. PubMed ID: 38429605
[TBL] [Abstract] [Full Text] [Related]
4. Low nuclear expression of HIF-hydroxylases PHD2/EGLN1 and PHD3/EGLN3 are associated with poor recurrence-free survival in clear cell renal cell carcinoma.
Luomala L; Mattila K; Vainio P; Nisén H; Pellinen T; Lohi J; Laajala TD; Järvinen P; Koskenniemi AR; Jaakkola P; Mirtti T
Cancer Med; 2024 Feb; 13(3):e6998. PubMed ID: 38400673
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic Targeting of Hypoxia-Inducible Factors in Cancer.
Musleh Ud Din S; Streit SG; Huynh BT; Hana C; Abraham AN; Hussein A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396737
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of HIF-1α expression and genetic polymorphisms in human clear cell renal cell carcinoma.
Vargova D; Kolková Z; Dargaj J; Bris L; Luptak J; Dankova Z; Franova S; Svihra J; Slávik P; Sutovska M
Pathol Oncol Res; 2023; 29():1611444. PubMed ID: 38273861
[No Abstract] [Full Text] [Related]
7. METTL3 facilitates renal cell carcinoma progression by PLOD2 m
Chen Y; He Y; Li Z; Zhang N; Zhou C; He X; Xue D
Cell Death Dis; 2024 Jan; 15(1):62. PubMed ID: 38233403
[TBL] [Abstract] [Full Text] [Related]
8. Long non-coding RNA hif1a-AS2 promotes carcinogenesis by enhancing Gli1-mediated HIF1α expression in clear cell renal cell carcinoma.
Li X; Wu Y; Xiao Z; Liu Y; Wang C; Zhou L; Yang X
Pathol Res Pract; 2024 Jan; 253():154984. PubMed ID: 38064865
[TBL] [Abstract] [Full Text] [Related]
9. [Activation of HIF-1α/ACLY signaling axis promotes progression of clear cell renal cell carcinoma with VHL inactivation mutation].
Ma Y; Wang YH; Huang S; Zou ZG; Hu L; Guo LC
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1230-1236. PubMed ID: 38058039
[No Abstract] [Full Text] [Related]
10. Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.
Liu T; Xiang W; Chen Z; Wang G; Cao R; Zhou F; Meng Z; Luo Y; Chen L
Cell Death Dis; 2023 Nov; 14(11):774. PubMed ID: 38008826
[TBL] [Abstract] [Full Text] [Related]
11. Evolution of the HIF targeted therapy in clear cell renal cell carcinoma.
Golijanin B; Malshy K; Khaleel S; Lagos G; Amin A; Cheng L; Golijanin D; Mega A
Cancer Treat Rev; 2023 Dec; 121():102645. PubMed ID: 37879247
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus.
Nakayama Y; Enomoto D; Yamamoto K; Takara K
Anticancer Res; 2023 Oct; 43(10):4349-4357. PubMed ID: 37772579
[TBL] [Abstract] [Full Text] [Related]
13. Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.
Mazzaschi G; Lazzarin A; Santoni M; Trentini F; Giorgi U; Brighi N; Tommasi C; Puglisi S; Caffo O; Kinspergher S; Mennitto A; Cattrini C; Verzoni E; Rametta A; Stellato M; Malgeri A; Roviello G; Silini EM; Rescigno P; Rebuzzi SE; Fornarini G; Quaini F; Giudice GC; Banna GL; Buti S
Front Biosci (Elite Ed); 2023 Jul; 15(3):20. PubMed ID: 37743233
[TBL] [Abstract] [Full Text] [Related]
14. Melatonin suppresses Akt/mTOR/S6K activity, induces cell apoptosis, and synergistically inhibits cell growth with sunitinib in renal carcinoma cells via reversing Warburg effect.
Xue KH; Jiang YF; Bai JY; Zhang DZ; Chen YH; Ma JB; Zhu ZJ; Wang X; Guo P
Redox Rep; 2023 Dec; 28(1):2251234. PubMed ID: 37642220
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy, mechanism, and safety of melatonin-loaded on thermosensitive nanogels for rabbit VX2 tumor embolization: A novel design.
Chen L; Sun T; Lv Y; Lu X; Li X; Zhang H; Qian K; Guo X; Sun B; Zhang W; Zhu L; Huang J; Liu Y; Zhao H; Zhao Y; Liang B; Zheng C
J Pineal Res; 2023 Oct; 75(3):e12900. PubMed ID: 37492880
[TBL] [Abstract] [Full Text] [Related]
16. Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel-Lindau-Disease-Associated tumors.
Suárez C; Vieito M; Valdivia A; González M; Carles J
Med Sci (Basel); 2023 Jun; 11(3):. PubMed ID: 37489462
[TBL] [Abstract] [Full Text] [Related]
17. Propofol Regulates HIF-1 α Effect of Expression of Targeted SIRT1 Signal pathway on kidney Renal Clear Cell Carcinoma.
Chen X; Li C; Zeng R; Qiu L; Huang J; Wang N; Ren X; Ling X
Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):145-149. PubMed ID: 37300675
[TBL] [Abstract] [Full Text] [Related]
18. Novel genetically engineered mouse models for clear cell renal cell carcinoma.
van der Mijn JC; Laursen KB; Fu L; Khani F; Dow LE; Nowak DG; Chen Q; Gross SS; Nanus DM; Gudas LJ
Sci Rep; 2023 May; 13(1):8246. PubMed ID: 37217526
[TBL] [Abstract] [Full Text] [Related]
19. VBP1 negatively regulates CHIP and selectively inhibits the activity of hypoxia-inducible factor (HIF)-1α but not HIF-2α.
Yue Y; Tang Y; Huang H; Zheng D; Liu C; Zhang H; Liu Y; Li Y; Sun X; Lu L
J Biol Chem; 2023 Jun; 299(6):104829. PubMed ID: 37201586
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-142-3p promotes renal cell carcinoma progression by targeting RhoBTB3 to regulate HIF-1 signaling and GGT/GSH pathways.
Zhang Y; Ma S; Zhang J; Lou L; Liu W; Gao C; Miao L; Sun F; Chen W; Cao X; Wei J
Sci Rep; 2023 Apr; 13(1):5935. PubMed ID: 37045834
[TBL] [Abstract] [Full Text] [Related]
[Next]
